The First Department of Propaedeutic and Internal Medicine at Laiko General Hospital has a research activity with participation to national and international Clinical Trials and Research Protocols. Selected Publications in Peer reviewed Scientific Journals are summarized here.<\/p>\n
2018<\/strong><\/p>\n Nocebos in rheumatology: emerging concepts and their implications for clinical practice.<\/p>\n Kravvariti E, Kitas GD, Mitsikostas DD, Sfikakis PP.<\/p>\n Nat Rev Rheumatol. 2018 Oct 25. doi: 10.1038\/s41584-018-0110-9. [Epub ahead of print] Review.<\/p>\n PMID: 30361674<\/p>\n Prevalence, Incidence, and Contributors of Subclinical Atheromatosis, Arteriosclerosis, and Arterial Hypertrophy in HIV-Infected Individuals: A Single-Center, 3-Year Prospective Study.<\/p>\n Psichogiou M, Kapelios CJ, Konstantonis G, Argyris A, Nasothimiou E, Papadopoulou M, Kitas G, Papaioannou TG, Daikos GL, Sfikakis PP, Protogerou AD.<\/p>\n Angiology. 2018 Sep 20:3319718801093. doi: 10.1177\/0003319718801093. [Epub ahead of print]<\/p>\n PMID: 30235944<\/p>\n Management of major organ involvement of Beh\u00e7et’s syndrome: a systematic review for update of the EULAR recommendations.<\/p>\n Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, \u00c7elik AF, Fortune F, Gaudric J, Gul A, K\u00f6tter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.<\/p>\n Rheumatology (Oxford). 2018 Aug 13. doi: 10.1093\/rheumatology\/key242. [Epub ahead of print]<\/p>\n PMID: 30107448<\/p>\n Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.<\/p>\n Kravvariti E, Konstantonis G, Sfikakis PP, Tektonidou MG.<\/p>\n Rheumatology (Oxford). 2018 Aug 8. doi: 10.1093\/rheumatology\/key233. [Epub ahead of print]<\/p>\n PMID: 30102390<\/p>\n Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.<\/p>\n Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Poulos G, Kolovou G, Theodorakis G, Kitas GD.<\/p>\n Rheumatol Int. 2018 Sep;38(9):1615-1621. doi: 10.1007\/s00296-018-4110-5. Epub 2018 Jul 24. Review.<\/p>\n PMID: 30043238<\/p>\n Management of skin, mucosa and joint involvement of Beh\u00e7et’s syndrome: A systematic review for update of the EULAR recommendations for the management of Beh\u00e7et’s syndrome.<\/p>\n Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, G\u00fcl A, K\u00f6tter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.<\/p>\n Semin Arthritis Rheum. 2018 May 19. pii: S0049-0172(18)30240-3. doi: 10.1016\/j.semarthrit.2018.05.008. [Epub ahead of print]<\/p>\n PMID: 29954598<\/p>\n Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.<\/a><\/p>\n Arida A, Protogerou AD, Kitas GD, Sfikakis PP.<\/p>\n Int J Mol Sci. 2018 Jun 27;19(7). pii: E1890. doi: 10.3390\/ijms19071890. Review.<\/p>\n PMID: 29954107<\/p>\n Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort.<\/a><\/p>\n Panopoulos S, Bournia VK, Konstantonis G, Fragiadaki K, Sfikakis PP, Tektonidou MG.<\/p>\n Autoimmun Rev. 2018 Aug;17(8):816-820. doi: 10.1016\/j.autrev.2018.02.008. Epub 2018 Jun 6.<\/p>\n PMID: 29885536<\/p>\n Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus.<\/a><\/p>\n Eleftheriadou I, Drosos GC, Tentolouris A, George K, Sfikakis PP, Protogerou AD, Tentolouris N.<\/p>\n J Hum Hypertens. 2018 Sep;32(8-9):531-539. doi: 10.1038\/s41371-018-0070-1. Epub 2018 May 23.<\/p>\n PMID: 29789692<\/p>\n Microwave Radiometry-Derived Thermal Changes of Small Joints as Additional Potential Biomarker in Rheumatoid Arthritis: A Prospective Pilot Study.<\/a><\/p>\n Pentazos G, Laskari K, Prekas K, Raftakis J, Sfikakis PP, Siores E.<\/p>\n J Clin Rheumatol. 2018 Aug;24(5):259-263. doi: 10.1097\/RHU.0000000000000719.<\/p>\n PMID: 29652702<\/p>\n 2018 update of the EULAR recommendations for the management of Beh\u00e7et’s syndrome.<\/a><\/p>\n Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, K\u00f6tter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.<\/p>\n Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136\/annrheumdis-2018-213225. Epub 2018 Apr 6.<\/p>\n PMID: 29625968<\/p>\n Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.<\/a><\/p>\n Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S, Staveri C, Klagou A, Tsalapaki C, Pantazi L, Konsta S, Mavragani CP, Dimopoulou D, Ntali S, Katsikas G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A, Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT.<\/p>\n Semin Arthritis Rheum. 2018 Feb 23. pii: S0049-0172(17)30803-X. doi: 10.1016\/j.semarthrit.2018.02.014. [Epub ahead of print]<\/p>\n PMID: 29555348<\/p>\n Can cardiovascular magnetic resonance prompt early cardiovascular\/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives.<\/a><\/p>\n Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Katsifis G, Markousis-Mavrogenis G, Kolovou G, Kitas GD.<\/p>\n Rheumatol Int. 2018 Jun;38(6):949-958. doi: 10.1007\/s00296-018-4004-6. Epub 2018 Mar 7. Review.<\/p>\n PMID: 29516170<\/p>\n Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease.<\/a><\/p>\n Felekos I, Aggeli C, Gialafos E, Kouranos V, Rapti A, Sfikakis P, Koulouris N, Tousoulis D.<\/p>\n Echocardiography. 2018 Jun;35(6):804-808. doi: 10.1111\/echo.13846. Epub 2018 Feb 28.<\/p>\n PMID: 29490113<\/p>\n Secukinumab after anti-tumour necrosis factor-\u03b1 therapy: a phase III study in active rheumatoid arthritis.<\/a><\/p>\n Dokoupilov\u00e1 E, Aelion J, Takeuchi T, Malavolta N, Sfikakis PP, Wang Y, Rohrer S, Richards HB.<\/p>\n Scand J Rheumatol. 2018 Jul;47(4):276-281. doi: 10.1080\/03009742.2017.1390605. Epub 2018 Feb 20.<\/p>\n PMID: 29458278<\/p>\n 24-hour aortic blood pressure variability showed a stronger association with carotid damage than 24-hour brachial blood pressure variability: The SAFAR study.<\/a><\/p>\n Yu S, Chi C, Protogerou AD, Safar ME, Blacher J, Argyris AA, Nasothimiou EG, Sfikakis PP, Papaioannou TG, Xu H, Zhang Y, Xu Y.<\/p>\n J Clin Hypertens (Greenwich). 2018 Mar;20(3):499-507. doi: 10.1111\/jch.13226. Epub 2018 Feb 19.<\/p>\n PMID: 29457351<\/p>\n Mechanisms of pulse pressure amplification dipping pattern during sleep time: the SAFAR study.<\/a><\/p>\n Argyris AA, Nasothimiou E, Aissopou E, Papaioannou TG, Zhang Y, Blacher J, Safar ME, Sfikakis PP, Protogerou AD.<\/p>\n J Am Soc Hypertens. 2018 Feb;12(2):117-127. doi: 10.1016\/j.jash.2017.12.005. Epub 2017 Dec 14.<\/p>\n PMID: 29287945<\/p>\n Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study.<\/a><\/p>\n Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG.<\/p>\n Semin Arthritis Rheum. 2018 Jun;47(6):883-889. doi: 10.1016\/j.semarthrit.2017.10.015. Epub 2017 Oct 23.<\/p>\n PMID: 29150207<\/p>\n Non-invasive vascular biomarkers in patients with Beh\u00e7et’s disease: review of the data and future perspectives.<\/a><\/p>\n Protogerou AD, Nasothimiou EG, Sfikakis PP, Tzioufas AG.<\/p>\n Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):100-107. Epub 2017 Oct 6. Review.<\/p>\n PMID: 29148423<\/p>\n High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients.<\/a><\/p>\n Thomas K, Flouri I, Repa A, Fragiadaki K, Sfikakis PP, Koutsianas C, Kaltsonoudis E, Voulgari PV, Drosos AA, Petrikkou E, Sidiropoulos P, Vassilopoulos D.<\/p>\n Clin Exp Rheumatol. 2018 Mar-Apr;36(2):254-262. Epub 2017 Nov 9.<\/p>\n PMID: 29148406<\/p>\n The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.<\/a><\/p>\n Papageorgiou SG, Kontos CK, Kotsianidis I, Vasilatou D, Symeonidis A, Galanopoulos A, Bouchla A, Hatzimichael E, Repousis P, Zikos P, Viniou NA, Poulakidas E, Vassilakopoulos TP, Diamantopoulos P, Diamantopoulos MA, Mparmparousi D, Bouronikou E, Papadaki H, Panayiotidis P, Pappa V.<\/p>\n Hematol Oncol. 2018 Oct;36(4):693-700. doi: 10.1002\/hon.2551. Epub 2018 Sep 7.<\/p>\n PMID: 30129144<\/p>\n Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group.<\/a><\/p>\n Papageorgiou SG, Kotsianidis I, Kontos CK, Symeonidis A, Galanopoulos A, Hatzimichael E, Poulakidas E, Diamantopoulos P, Vassilakopoulos TP, Zikos P, Papadaki H, Bouronikou E, Panayiotidis P, Viniou NA, Pappa V.<\/p>\n Leuk Res. 2018 Aug;71:55-59. doi: 10.1016\/j.leukres.2018.07.004. Epub 2018 Jul 7. No abstract available.<\/p>\n PMID: 30007218<\/p>\n Efficacy-safety of Facilitated Subcutaneous Immunoglobulin in Immunodeficiency Due to Hematological Malignancies. A Single-Center Retrospective Analysis.<\/a><\/p>\n Dimou M, Iliakis T, Maltezas D, Bitsani A, Kalyva S, Koudouna A, Kotsanti S, Petsa P, Papaioannou P, Kyrtsonis MC, Panayiotidis P.<\/p>\n Anticancer Res. 2018 Jul;38(7):4187-4191. doi: 10.21873\/anticanres.12712.<\/p>\n PMID: 29970548<\/p>\n Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.<\/a><\/p>\n Tsirigotis P, Vassilakopoulos T, Batsis I, Bousiou Z, Gkirkas K, Sakellari I, Kaloyannidis P, Roussou P, Pangalis GA, Moschogiannis M, Vassilopoulos G, Repousis P, Megalakaki A, Michalis E, Kalpadakis C, Papadaki HA, Kotsianidis I, Hatzimichael E, Spyridonidis A, Anargyrou K, Poulakidas E, Giannoullia P, Apostolidis I, Stamouli M, Konstantopoulos K, Pappa V, Panayiotidis P, Harhalakis N, Anagnostopoulos A, Angelopoulou M.<\/p>\n Hematol Oncol. 2018 Oct;36(4):645-650. doi: 10.1002\/hon.2521. Epub 2018 Jun 8.<\/p>\n PMID: 29882363<\/p>\n Primary Hepatic Burkitt Lymphoma in a Kidney Transplant Recipient.<\/a><\/p>\n Lionaki S, Tsakonas E, Androulaki A, Liapis G, Panayiotidis P, Zavos G, Boletis JN.<\/p>\n Case Rep Nephrol. 2018 May 13;2018:7425785. doi: 10.1155\/2018\/7425785. eCollection 2018.<\/p>\n PMID: 29862100<\/p>\n Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.<\/a><\/p>\n Saussele S, Richter J, Guilhot J, Gruber FX, Hjorth-Hansen H, Almeida A, Janssen JJWM, Mayer J, Koskenvesa P, Panayiotidis P, Olsson-Str\u00f6mberg U, Martinez-Lopez J, Rousselot P, Vestergaard H, Ehrencrona H, Kairisto V, Machov\u00e1 Pol\u00e1kov\u00e1 K, M\u00fcller MC, Mustjoki S, Berger MG, Fabarius A, Hofmann WK, Hochhaus A, Pfirrmann M, Mahon FX; EURO-SKI investigators.<\/p>\n Lancet Oncol. 2018 Jun;19(6):747-757. doi: 10.1016\/S1470-2045(18)30192-X. Epub 2018 May 4.<\/p>\n PMID: 29735299<\/p>\n The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.<\/a><\/p>\n Papageorgiou SG, Vasilatou D, Kontos CK, Kotsianidis I, Symeonidis A, Galanopoulos AG, Hatzimichael E, Megalakaki A, Poulakidas E, Diamantopoulos P, Vassilakopoulos TP, Zikos P, Papadaki H, Mparmparousi D, Bouronikou E, Panayiotidis P, Viniou NA, Pappa V.<\/p>\n Am J Hematol. 2018 Jul;93(7):895-901. doi: 10.1002\/ajh.25111. Epub 2018 May 16.<\/p>\n PMID: 29659040<\/p>\n Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy\/autologous hematopoietic stem cell transplantation.<\/a><\/p>\n Boutsikas G, Terpos E, Papatheodorou A, Tsirkinidis P, Tsirigotis P, Meletiou A, Lalou E, Telonis V, Zannou A, Kanellopoulos A, Galani Z, Stefanou A, Tsaftaridis P, Viniou NA, Panayiotidis P, Kyrtsonis MC, Meletis J, Vassilakopoulos TP, Angelopoulou MK.<\/p>\n Eur J Haematol. 2018 Feb;100(2):131-139. doi: 10.1111\/ejh.12990. Epub 2017 Dec 4.<\/p>\n PMID: 29105864<\/p>\n The Significance of PET\/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials.<\/a><\/p>\n Angelopoulou MK, Mosa E, Pangalis GA, Rondogianni P, Chatziioannou S, Prassopoulos V, Moschogianni M, Tsirkinidis P, Asimakopoulos JV, Konstantinou I, Tsourouflis G, Sachanas S, Yiakoumis X, Boutsikas G, Arapaki M, Gainaru G, Kyrtsonis MC, Siakantaris MP, Datseris I, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP.<\/p>\n Anticancer Res. 2017 Oct;37(10):5727-5736.<\/p>\n PMID: 28982893<\/p>\n Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.<\/a><\/p>\n Dreyling M, Santoro A, Mollica L, Lepp\u00e4 S, Follows GA, Lenz G, Kim WS, Nagler A, Panayiotidis P, Demeter J, \u00d6zcan M, Kosinova M, Bouabdallah K, Morschhauser F, Stevens DA, Trevarthen D, Giurescu M, Cupit L, Liu L, K\u00f6chert K, Seidel H, Pe\u00f1a C, Yin S, Hiemeyer F, Garcia-Vargas J, Childs BH, Zinzani PL.<\/p>\n J Clin Oncol. 2017 Dec 10;35(35):3898-3905. doi: 10.1200\/JCO.2017.75.4648. Epub 2017 Oct 4.<\/p>\n PMID: 28976790<\/p>\n High-grade B-cell lymphoma of the peritoneum as a result of transformation of a CD5-negative monoclonal B lymphocytosis population in a patient with myelodysplastic syndrome treated with 5-azacytidine.<\/a><\/p>\n Dimou M, Roumelioti M, Dimitrakopoulou A, Bitsani C, Kotsanti S, Petsa P, Papaioannou P, Kyrtsonis MC, Panayiotidis P.<\/p>\n Leuk Lymphoma. 2018 May;59(5):1264-1267. doi: 10.1080\/10428194.2017.1375108. Epub 2017 Sep 13. No abstract available.<\/p>\n PMID: 28901815<\/p>\n Bone metabolism markers and angiogenic cytokines as regulators of human hematopoietic stem cell mobilization.<\/a><\/p>\n Tsirkinidis P, Terpos E, Boutsikas G, Papatheodorou A, Anargyrou K, Lalou E, Dimitrakopoulou A, Kalpadakis C, Konstantopoulos K, Siakantaris M, Panayiotidis P, Pangalis G, Kyrtsonis MC, Vassilakopoulos T, Angelopoulou MK.<\/p>\n J Bone Miner Metab. 2018 Jul;36(4):399-409. doi: 10.1007\/s00774-017-0853-4. Epub 2017 Jun 28.<\/p>\n PMID: 28660376<\/p>\n Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-\u03b3 expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications.<\/a><\/p>\n P Vassilakopoulos T, Levidou G, Milionis V, Hartmann S, Lakiotaki E, Sepsa A, Thymara I, Ntailiani P, Spanou K, K Angelopoulou M, P Siakantaris M, Moschogiannis M, A Pangalis G, Panayiotidis P, Konstantopoulos K, Patsouris E, Hansmann ML, Korkolopoulou P.<\/p>\n Leuk Lymphoma. 2017 Sep;58(9):1-13. doi: 10.1080\/10428194.2017.1289520. Epub 2017 Jun 2.<\/p>\n PMID: 28571489<\/p>\n Brentuximab vedotin in relapsed\/refractory Hodgkin lymphoma. The Hellenic experience.<\/a><\/p>\n Angelopoulou MK, Vassilakopoulos TP, Batsis I, Sakellari I, Gkirkas K, Pappa V, Giannoulia P, Apostolidis I, Apostolopoulos C, Roussou P, Panayiotidis P, Dimou M, Kyrtsonis MC, Palassopoulou M, Vassilopoulos G, Moschogiannis M, Kalpadakis C, Margaritis D, Spyridonidis A, Michalis E, Anargyrou K, Repousis P, Hatzimichael E, Bousiou Z, Poulakidas E, Grentzelias D, Harhalakis N, Pangalis GA, Anagnostopoulos A, Tsirigotis P.<\/p>\n Hematol Oncol. 2018 Feb;36(1):174-181. doi: 10.1002\/hon.2383. Epub 2017 Feb 20.<\/p>\n PMID: 28219112<\/p>\n Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms.<\/a><\/p>\n Daskalakis K, Chatzelis E, Tsoli M, Papadopoulou-Marketou N, Dimitriadis GK, Tsolakis AV, Kaltsas G.<\/p>\n Endocrine. 2018 Oct 2. doi: 10.1007\/s12020-018-1773-3. [Epub ahead of print]<\/p>\n PMID: 30280284<\/p>\n Iodine intake and chronic autoimmune thyroiditis: a comparative study between coastal and mainland regions in Greece.<\/a><\/p>\n Giassa \u03a4, Mamali I, Gaki \u0395, Kaltsas G, Kouraklis G, Markou \u039a\u0392, Karatzas T.<\/p>\n Hormones (Athens). 2018 Sep 28. doi: 10.1007\/s42000-018-0057-x. [Epub ahead of print]<\/p>\n PMID: 30267376<\/p>\n Unmet medical needs in pulmonary neuroendocrine (carcinoid) neoplasms.<\/a><\/p>\n Baudin E, Hayes A, Scoazec JY, Filosso PL, Lim E, Kaltsas G, Frilling A, Chen J, Kos-Kudla B, Gorbounova V, Wiedenmann B, Nieveen van Dijkum E, Cwikla J, Falkerby J, Valle JW, Kulke MH, Caplin M.<\/p>\n Neuroendocrinology. 2018 Sep 24. doi: 10.1159\/000493980. [Epub ahead of print]<\/p>\n PMID: 30248673<\/p>\n Lung Carcinoids: long-term surgical results and the lack of prognostic value of somatostatin receptors and other novel IHC markers. <br>.<\/a><\/p>\n Daskalakis K, Kaltsas G, \u00d6berg K, Tsolakis AV.<\/p>\n Neuroendocrinology. 2018 Sep 23. doi: 10.1159\/000493944. [Epub ahead of print]<\/p>\n PMID: 30244255<\/p>\n Unmet needs in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3).<\/a><\/p>\n Sorbye H, Baudin E, Borbath I, Caplin M, Chen J, Cwikla J, Frilling A, Grossman A, Kaltsas G, Scarpa A, Welin S, Garcia-Carbonero R.<\/p>\n Neuroendocrinology. 2018 Aug 28. doi: 10.1159\/000493318. [Epub ahead of print]<\/p>\n PMID: 30153658<\/p>\n Gastric Carcinoids.<\/a><\/p>\n Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S, Kaltsas G.<\/p>\n Endocrinol Metab Clin North Am. 2018 Sep;47(3):645-660. doi: 10.1016\/j.ecl.2018.04.013. Epub 2018 Jul 11. Review.<\/p>\n PMID: 30098721<\/p>\n Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms.<\/a><\/p>\n Kyriakopoulos G, Mavroeidi V, Chatzellis E, Kaltsas GA, Alexandraki KI.<\/p>\n Ann Transl Med. 2018 Jun;6(12):252. doi: 10.21037\/atm.2018.06.27. Review.<\/p>\n PMID: 30069454<\/p>\n Effects of visfatin on brown adipose tissue energy regulation using T37i cells.<\/a><\/p>\n Dimitriadis GK, Adya R, Tan BK, Jones TA, Menon VS, Ramanjaneya M, Kaltsas G, Miras AD, Randeva HS.<\/p>\n Cytokine. 2018 Jul 27. pii: S1043-4666(18)30299-0. doi: 10.1016\/j.cyto.2018.07.013. [Epub ahead of print]<\/p>\n PMID: 30060995<\/p>\n Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.<\/a><\/p>\n Nasiri-Ansari \u039d, Dimitriadis GK, Agrogiannis G, Perrea D, Kostakis ID, Kaltsas G, Papavassiliou AG, Randeva HS, Kassi E.<\/p>\n Cardiovasc Diabetol. 2018 Jul 26;17(1):106. doi: 10.1186\/s12933-018-0749-1.<\/p>\n PMID: 30049285<\/p>\n Bone metabolism in Langerhans cell histiocytosis.<\/a><\/p>\n Anastasilakis AD, Tsoli M, Kaltsas G, Makras P.<\/p>\n Endocr Connect. 2018 Jul;7(7):R246-R253. doi: 10.1530\/EC-18-0186. Epub 2018 Jul 2. Review.<\/p>\n PMID: 29967185<\/p>\n Advances on systemic treatment for lung neuroendocrine neoplasms.<\/a><\/p>\n Tsoukalas N, Baxevanos P, Aravantinou-Fatorou E, Tolia M, Galanopoulos M, Tsapakidis K, Kyrgias G, Toumpanakis C, Kaltsas G.<\/p>\n Ann Transl Med. 2018 Apr;6(8):146. doi: 10.21037\/atm.2018.04.03. Review.<\/p>\n PMID: 29862235<\/p>\n Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids?<\/a><\/p>\n Kanakis GA, Grimelius L, Papaioannou D, Kaltsas G, Tsolakis AV.<\/p>\n Oncotarget. 2018 Apr 27;9(32):22653-22664. doi: 10.18632\/oncotarget.25203. eCollection 2018 Apr 27.<\/p>\n PMID: 29854305<\/p>\n The value of prolactin in predicting prolactin\u03bfma in hyperprolactinaemic polycystic ovarian syndrome.<\/a><\/p>\n Kyritsi EM, Dimitriadis GK, Angelousi A, Mehta H, Shad A, Mytilinaiou M, Kaltsas G, Randeva HS.<\/p>\n Eur J Clin Invest. 2018 Jul;48(7):e12961. doi: 10.1111\/eci.12961. Epub 2018 Jun 13.<\/p>\n PMID: 29845629<\/p>\n Supplementation of Vitamin D Deficiency in Patients with Neuroendocrine Tumors Using Over-the-Counter Vitamin D3 Preparations.<\/a><\/p>\n Robbins HL, Symington M, Mosterman B, Goodby J, Davies L, Dimitriadis GK, Kaltsas G, Randeva HS, Weickert MO.<\/p>\n Nutr Cancer. 2018 Jul;70(5):748-754. doi: 10.1080\/01635581.2018.1470650. Epub 2018 May 21.<\/p>\n PMID: 29781720<\/p>\n Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome.<\/a><\/p>\n Weickert MO, Kaltsas G, H\u00f6rsch D, Lapuerta P, Pavel M, Valle JW, Caplin ME, Bergsland E, Kunz PL, Anthony LB, Grande E, \u00d6berg K, Welin S, Lombard-Bohas C, Ramage JK, Kittur A, Yang QM, Kulke MH.<\/p>\n Clin Ther. 2018 Jun;40(6):952-962.e2. doi: 10.1016\/j.clinthera.2018.04.006. Epub 2018 May 1.<\/p>\n PMID: 29724499<\/p>\n Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion.<\/a><\/p>\n Dimitriadis GK, Kaur J, Adya R, Miras AD, Mattu HS, Hattersley JG, Kaltsas G, Tan BK, Randeva HS.<\/p>\n Oncotarget. 2018 Mar 30;9(24):16678-16690. doi: 10.18632\/oncotarget.24659. eCollection 2018 Mar 30.<\/p>\n PMID: 29682177<\/p>\n Clock genes alterations and endocrine disorders.<\/a><\/p>\n Angelousi A, Kassi E, Nasiri-Ansari N, Weickert MO, Randeva H, Kaltsas G.<\/p>\n Eur J Clin Invest. 2018 Jun;48(6):e12927. doi: 10.1111\/eci.12927. Epub 2018 Apr 16. Review.<\/p>\n PMID: 29577261<\/p>\n Clinical, Endocrine and Imaging Characteristics of Patients with Primary Hypophysitis.<\/a><\/p>\n Angelousi A, Cohen C, Sosa S, Danilowicz K, Papanastasiou L, Tsoli M, Pal A, Piaditis G, Grossman A, Kaltsas G.<\/p>\n Horm Metab Res. 2018 Apr;50(4):296-302. doi: 10.1055\/s-0044-101036. Epub 2018 Feb 19.<\/p>\n PMID: 29458219<\/p>\n Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.<\/a><\/p>\n Grozinsky-Glasberg S, Kaltsas G, Kaltsatou M, Lev-Cohain N, Klimov A, Vergadis V, Uri I, Bloom AI, Gross DJ.<\/p>\n Endocrine. 2018 Jun;60(3):499-509. doi: 10.1007\/s12020-018-1537-0. Epub 2018 Jan 30.<\/p>\n PMID: 29383678<\/p>\n Comparison of health-related quality of Life (HRQOL) among patients with pre-diabetes, diabetes and normal glucose tolerance, using the 15D-HRQOL questionnaire in Greece: the DEPLAN study.<\/a><\/p>\n Makrilakis K, Liatis S, Tsiakou A, Stathi C, Papachristoforou E, Perrea D, Katsilambros N, Kontodimopoulos N, Niakas D.<\/p>\n BMC Endocr Disord. 2018 May 29;18(1):32. doi: 10.1186\/s12902-018-0261-3.<\/p>\n PMID: 29843700<\/p>\n Follistatins in glucose regulation of healthy and obese subjects.<\/a><\/p>\n Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS.<\/p>\n Diabetes Obes Metab. 2018 Nov 4. doi: 10.1111\/dom.13572. [Epub ahead of print]<\/p>\n PMID: 30393997<\/p>\n Advancements in improving health-related quality of life in patients living with diabetic foot ulcers.<\/a><\/p>\n Tzeravini E, Tentolouris A, Tentolouris N, Jude EB.<\/p>\n Expert Rev Endocrinol Metab. 2018 Oct 29:1-10. doi: 10.1080\/17446651.2018.1541403. [Epub ahead of print]<\/p>\n PMID: 30381974<\/p>\n Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia.<\/a><\/p>\n Grigoropoulou P, Tentolouris A, Eleftheriadou I, Tsilingiris D, Vlachopoulos C, Sykara M, Tentolouris N.<\/p>\n Diab Vasc Dis Res. 2018 Oct 17:1479164118805320. doi: 10.1177\/1479164118805320. [Epub ahead of print]<\/p>\n PMID: 30328360<\/p>\n Effectiveness of artificial pancreas in the non-adult population: a systematic review and network meta-analysis.<\/a><\/p>\n Karageorgiou V, Papaioannou TG, Bellos I, Alexandraki K, Tentolouris N, Stefanadis C, Chrousos GP, Tousoulis D.<\/p>\n Metabolism. 2018 Oct 12. pii: S0026-0495(18)30212-9. doi: 10.1016\/j.metabol.2018.10.002. [Epub ahead of print] Review.<\/p>\n PMID: 30321535<\/p>\n Pain management of chronic wounds: Diabetic ulcers and beyond.<\/a><\/p>\n Paschou SA, Stamou M, Vuagnat H, Tentolouris N, Jude E.<\/p>\n Maturitas. 2018 Nov;117:17-21. doi: 10.1016\/j.maturitas.2018.08.013. Epub 2018 Sep 5. Review.<\/p>\n PMID: 30314556<\/p>\n Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.<\/a><\/p>\n Hernandez AF, Green JB, Janmohamed S, D’Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators.<\/p>\n Lancet. 2018 Oct 1. pii: S0140-6736(18)32261-X. doi: 10.1016\/S0140-6736(18)32261-X. [Epub ahead of print]<\/p>\n PMID: 30291013<\/p>\n Plasma Irisin Levels in Subjects with Type 1 Diabetes: Comparison with Healthy Controls.<\/a><\/p>\n Tentolouris A, Eleftheriadou I, Tsilingiris D, Anastasiou IA, Kosta OA, Mourouzis I, Kokkinos A, Pantos C, Katsilambros N, Tentolouris N.<\/p>\n Horm Metab Res. 2018 Nov;50(11):803-810. doi: 10.1055\/a-0748-6170. Epub 2018 Oct 4.<\/p>\n PMID: 30286484<\/p>\n Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.<\/a><\/p>\n Liakos A, Lambadiari V, Bargiota A, Kitsios K, Avramidis I, Kotsa K, Gerou S, Boura P, Tentolouris N, Dimitriadis G, Tsapas A.<\/p>\n Diabetes Obes Metab. 2018 Sep 22. doi: 10.1111\/dom.13541. [Epub ahead of print]<\/p>\n PMID: 30242948<\/p>\n Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis.<\/a><\/p>\n Liaskos C, Koliaki C, Alexiadou K, Argyrakopoulou G, Tentolouris N, Diamantis T, Alexandrou A, Katsilambros N, Kokkinos A.<\/p>\n Obes Surg. 2018 Dec;28(12):3997-4005. doi: 10.1007\/s11695-018-3454-y.<\/p>\n PMID: 30112599<\/p>\n Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.<\/a><\/p>\n Mamakou V, Hackinger S, Zengini E, Tsompanaki E, Marouli E, Serafetinidis I, Prins B, Karabela A, Glezou E, Southam L, Rayner NW, Kuchenbaecker K, Lamnissou K, Kontaxakis V, Dedoussis G, Gonidakis F, Thanopoulou A, Tentolouris N, Zeggini E.<\/p>\n BMC Psychiatry. 2018 Aug 2;18(1):249. doi: 10.1186\/s12888-018-1826-4.<\/p>\n PMID: 30071838<\/p>\n Diabetic Foot Infections: Update on Management.<\/a><\/p>\n Nikoloudi M, Eleftheriadou I, Tentolouris A, Kosta OA, Tentolouris N.<\/p>\n Curr Infect Dis Rep. 2018 Aug 1;20(10):40. doi: 10.1007\/s11908-018-0645-6. Review.<\/p>\n PMID: 30069605<\/p>\n The Effect of the Oral Administration of Leucine on Endothelial Function, Glucose and Insulin Concentrations in Healthy Subjects.<\/a><\/p>\n Argyrakopoulou G, Kontrafouri P, Eleftheriadou I, Kokkinos A, Arapostathi C, Kyriaki D, Perrea D, Revenas C, Katsilambros N, Tentolouris N.<\/p>\n Exp Clin Endocrinol Diabetes. 2018 Jun 11. doi: 10.1055\/a-0597-8985. [Epub ahead of print]<\/p>\n PMID: 29890542<\/p>\n Schizophrenia and type 2 diabetes mellitus.<\/a><\/p>\n Mamakou V, Thanopoulou A, Gonidakis F, Tentolouris N, Kontaxakis V.<\/p>\n Psychiatriki. 2018 Jan-Mar;29(1):64-73. doi: 10.22365\/jpsych.2018.291.64. Review.<\/p>\n PMID: 29754122<\/p>\n Prevalence of diabetes mellitus as well as cardiac and other main comorbidities in a representative sample of the adult Greek population in comparison with the general population.<\/a><\/p>\n Tentolouris A, Eleftheriadou I, Athanasakis K, Kyriopoulos J, Tsilimigras DI, Grigoropoulou P, Doupis J, Tentolouris N.<\/p>\n Hellenic J Cardiol. 2018 May 3. pii: S1109-9666(18)30038-1. doi: 10.1016\/j.hjc.2018.04.008. [Epub ahead of print]<\/p>\n PMID: 29729413<\/p>\n Hypertension in patients with type 2 diabetes mellitus: Targets and management.<\/a><\/p>\n Pavlou DI, Paschou SA, Anagnostis P, Spartalis M, Spartalis E, Vryonidou A, Tentolouris N, Siasos G.<\/p>\n Maturitas. 2018 Jun;112:71-77. doi: 10.1016\/j.maturitas.2018.03.013. Epub 2018 Mar 30. Review.<\/p>\n PMID: 29704920<\/p>\n Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes.<\/a><\/p>\n Tentolouris A, Eleftheriadou I, Tentolouris N.<\/p>\n Ann Transl Med. 2018 Feb;6(3):63. doi: 10.21037\/atm.2017.12.28. No abstract available.<\/p>\n PMID: 29610753<\/p>\n Effect of \u03b1-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy.<\/a><\/p>\n Agathos E, Tentolouris A, Eleftheriadou I, Katsaouni P, Nemtzas I, Petrou A, Papanikolaou C, Tentolouris N.<\/p>\n J Int Med Res. 2018 May;46(5):1779-1790. doi: 10.1177\/0300060518756540. Epub 2018 Mar 8.<\/p>\n PMID: 29517942<\/p>\n Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity.<\/a><\/p>\n Tsiompanidis E, Siakavellas SI, Tentolouris A, Eleftheriadou I, Chorepsima S, Manolakis A, Oikonomou K, Tentolouris N.<\/p>\n World J Gastrointest Pathophysiol. 2018 Feb 15;9(1):28-36. doi: 10.4291\/wjgp.v9.i1.28.<\/p>\n PMID: 29487764<\/p>\n Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial.<\/a><\/p>\n Billings LK, Doshi A, Gouet D, Oviedo A, Rodbard HW, Tentolouris N, Gr\u00f8n R, Halladin N, Jodar E.<\/p>\n Diabetes Care. 2018 May;41(5):1009-1016. doi: 10.2337\/dc17-1114. Epub 2018 Feb 26.<\/p>\n PMID: 29483185<\/p>\n Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors.<\/a><\/p>\n Bistola V, Lambadiari V, Dimitriadis G, Ioannidis I, Makrilakis K, Tentolouris N, Tsapas A, Parissis J.<\/p>\n Heart Fail Rev. 2018 May;23(3):377-388. doi: 10.1007\/s10741-018-9674-3. Review.<\/p>\n PMID: 29383638<\/p>\n Associations between adiponectin gene variability, pro-inflammatory and angiogenetic markers: implications for microvascular disease development in type 2 diabetes mellitus?<\/a><\/p>\n Kollia C, Antonopoulos AS, Siasos G, Konsola T, Oikonomou E, Gouliopoulos N, Tsigkou V, Papapanagiotou A, Kassi E, Tentolouris N, Katsiki N, Vavuranakis M, Papavassiliou AG, Tousoulis D.<\/p>\n Curr Vasc Pharmacol. 2018 Jan 7. doi: 10.2174\/1570161116666180108113825. [Epub ahead of print]<\/p>\n PMID: 29308741<\/p>\n A school- and community-based intervention to promote healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe: design and implementation of the Feel4Diabetes-study.<\/a><\/p>\n Manios Y, Androutsos O, Lambrinou CP, Cardon G, Lindstrom J, Annemans L, Mateo-Gallego R, de Sabata MS, Iotova V, Kivela J, Martinez R, Moreno LA, Rurik I, Schwarz P, Tankova T, Liatis S, Makrilakis K.<\/p>\n Public Health Nutr. 2018 Sep 12:1-10. doi: 10.1017\/S1368980018002136. [Epub ahead of print]<\/p>\n PMID: 30207513<\/p>\n Gaps in Guidelines for the Management of Diabetes in Low- and Middle-Income Versus High-Income Countries-A Systematic Review.<\/a><\/p>\n Owolabi MO, Yaria JO, Daivadanam M, Makanjuola AI, Parker G, Oldenburg B, Vedanthan R, Norris S, Oguntoye AR, Osundina MA, Herasme O, Lakoh S, Ogunjimi LO, Abraham SE, Olowoyo P, Jenkins C, Feng W, Bayona H, Mohan S, Joshi R, Webster R, Kengne AP, Trofor A, Lotrean LM, Praveen D, Zafra-Tanaka JH, Lazo-Porras M, Bobrow K, Riddell MA, Makrilakis K, Manios Y, Ovbiagele B; COUNCIL Initiative.<\/p>\n Diabetes Care. 2018 May;41(5):1097-1105. doi: 10.2337\/dc17-1795. Review.<\/p>\n PMID: 29678866<\/p>\n Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros.<\/a><\/p>\n Makrilakis K, Liatis S.<\/p>\n J Diabetes Res. 2017;2017:8927473. doi: 10.1155\/2017\/8927473. Epub 2017 Dec 14. Review.<\/p>\n PMID: 29387731<\/p>\n Antidiabetic Drugs as Antihypertensives: New Data on the Horizon.<\/a><\/p>\n Mamakou V, Eleftheriadou I, Katsiki N, Makrilakis K, Tsioufis K, Tentolouris N.<\/p>\n Curr Vasc Pharmacol. 2017;16(1):70-78. doi: 10.2174\/1570161115666171010122332. Review.<\/p>\n PMID: 29032756<\/p>\n Hypoglycaemia causes both daytime and nighttime QTc interval prolongation in patients with type 2 diabetes receiving insulin treatment.<\/a><\/p>\n Makrilakis K, Stathi C, Vlahodimitris I, Kalopita S, Thomakos P, Konstantopoulos P, Perrea D, Katsilambros N, Liatis S.<\/p>\n Diabetes Metab. 2018 Mar;44(2):175-177. doi: 10.1016\/j.diabet.2017.08.005. Epub 2017 Oct 10. No abstract available.<\/p>\n PMID: 29029946<\/p>\n Correction to: Real-world data on Len\/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.<\/a><\/p>\n Katodritou E, Kyrtsonis MC, Delimpasi S, Kyriakou D, Symeonidis A, Spanoudakis E, Vasilopoulos G, Anagnostopoulos A, Kioumi A, Zikos P, Aktypi A, Briasoulis E, Megalakaki A, Repousis P, Adamopoulos I, Gogos D, Kotsopoulou M, Pappa V, Papadaki E, Fotiou D, Nikolaou E, Giannopoulou E, Hatzimichael E, Giannakoulas N, Douka V, Kokoviadou K, Timotheatou D, Terpos E.<\/p>\n Ann Hematol. 2018 Sep;97(9):1747. doi: 10.1007\/s00277-018-3404-8.<\/p>\n PMID: 29943159<\/p>\n Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.<\/a><\/p>\n Kalpadakis C, Pangalis GA, Sachanas S, Tsirkinidis P, Kontopidou FN, Moschogiannis M, Yiakoumis X, Koulieris E, Dimopoulou MN, Kokkoris SI, Kyrtsonis MC, Siakantaris MP, Tsourouflis G, Korkolopoulou P, Rontogianni D, Tsaftaridis P, Plata E, Papadaki HA, Panagiotidis P, Angelopoulou MK, Vassilakopoulos TP.<\/p>\n Blood. 2018 Aug 9;132(6):666-670. doi: 10.1182\/blood-2018-02-833608. Epub 2018 Jun 18. No abstract available.<\/p>\n PMID: 29914978<\/p>\n Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstr\u00f6m’s Macroglobulinemia.<\/a><\/p>\n Dimopoulos MA, Tedeschi A, Trotman J, Garc\u00eda-Sanz R, Macdonald D, Leblond V, Mahe B, Herbaux C, Tam C, Orsucci L, Palomba ML, Matous JV, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C; iNNOVATE Study Group and the European Consortium for Waldenstr\u00f6m\u2019s Macroglobulinemia.<\/p>\n N Engl J Med. 2018 Jun 21;378(25):2399-2410. doi: 10.1056\/NEJMoa1802917. Epub 2018 Jun 1.<\/p>\n PMID: 29856685<\/p>\n Real-world data on Len\/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.<\/a><\/p>\n Katodritou E, Kyrtsonis MC, Delimpasi S, Kyriakou D, Symeonidis A, Spanoudakis E, Vasilopoulos G, Anagnostopoulos A, Kioumi A, Zikos P, Aktypi A, Briasoulis E, Megalakaki A, Repousis P, Adamopoulos I, Gogos D, Kotsopoulou M, Pappa V, Papadaki E, Fotiou D, Nikolaou E, Giannopoulou E, Hatzimichael E, Giannakoulas N, Douka V, Kokoviadou K, Timotheatou D, Terpos E.<\/p>\n Ann Hematol. 2018 Sep;97(9):1671-1682. doi: 10.1007\/s00277-018-3361-2. Epub 2018 May 13. Erratum in: Ann Hematol. 2018 Jun 26;:<\/a>.<\/p>\n PMID: 29756171<\/p>\n Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.<\/a><\/p>\n Katodritou E, Terpos E, Delimpasi S, Kotsopoulou M, Michalis E, Vadikolia C, Kyrtsonis MC, Symeonidis A, Giannakoulas N, Vadikolia C, Michael M, Kalpadakis C, Gougopoulou T, Prokopiou C, Kaiafa G, Christoulas D, Gavriatopoulou M, Giannopoulou E, Labropoulou V, Verrou E, Kastritis E, Konstantinidou P, Anagnostopoulos A, Dimopoulos MA.<\/p>\n Blood Cancer J. 2018 Mar 9;8(3):31. doi: 10.1038\/s41408-018-0059-6.<\/p>\n PMID: 29523783<\/p>\n Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.<\/a><\/p>\n Zagouri F, Kastritis E, Zomas A, Terpos E, Katodritou E, Symeonidis A, Delimpasi S, Pouli A, Vassilakopoulos TP, Michalis E, Giannouli S, Kartasis Z, Christoforidou A, Kokoviadou K, Hatzimichael E, Gika D, Megalakaki C, Papaioannou M, Kyrtsonis MC, Konstantopoulos K, Dimopoulos MA; Greek Myeloma Study Group.<\/p>\n Eur J Haematol. 2017 Nov;99(5):409-414. doi: 10.1111\/ejh.12923. Epub 2017 Sep 26.<\/p>\n PMID: 28675766<\/p>\n Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.<\/a><\/p>\n de Jes\u00fas GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA; APS ACTION.<\/p>\n BJOG. 2018 Sep 17. doi: 10.1111\/1471-0528.15469. [Epub ahead of print]<\/p>\n PMID: 30222236<\/p>\n Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.<\/a><\/p>\n Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM.<\/p>\n Clin Rheumatol. 2018 Aug 25. doi: 10.1007\/s10067-018-4267-z. [Epub ahead of print]<\/p>\n PMID: 30145635<\/p>\n Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.<\/a><\/p>\n Tektonidou MG.<\/p>\n Front Immunol. 2018 May 31;9:1181. doi: 10.3389\/fimmu.2018.01181. eCollection 2018. Review.<\/p>\n PMID: 29904380<\/p>\n B-cell activating factor and related genetic variants in lupus related atherosclerosis.<\/a><\/p>\n Theodorou E, Nezos A, Antypa E, Ioakeimidis D, Koutsilieris M, Tektonidou M, Moutsopoulos HM, Mavragani CP.<\/p>\n J Autoimmun. 2018 Aug;92:87-92. doi: 10.1016\/j.jaut.2018.05.002. Epub 2018 May 31.<\/p>\n PMID: 29859654<\/p>\n The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody Positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository.<\/a><\/p>\n Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG; TheBehalf of APS ACTION.<\/p>\n Arthritis Care Res (Hoboken). 2018 Apr 18. doi: 10.1002\/acr.23584. [Epub ahead of print]<\/p>\n PMID: 29669399<\/p>\n The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients.<\/a><\/p>\n Rodr\u00edguez-Pint\u00f3 I, Espinosa G, Erkan D, Shoenfeld Y, Cervera R; CAPS Registry Project Group .<\/p>\n Rheumatology (Oxford). 2018 Apr 11. doi: 10.1093\/rheumatology\/key082. [Epub ahead of print]<\/p>\n PMID: 29660074<\/p>\n Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy.<\/a><\/p>\n Jackson WG, Oromendia C, Unlu O, Erkan D, DeSancho MT; Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking.<\/p>\n Blood Adv. 2017 Nov 16;1(25):2320-2324. doi: 10.1182\/bloodadvances.2017008185. eCollection 2017 Nov 28.<\/p>\n PMID: 29296881<\/p>\n Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus.<\/a><\/p>\n Mavrogeni S, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Bounas A, Tektonidou M, Lliossis SC, Daoussis D, Plastiras S, Karabela G, Stavropoulos E, Katsifis G, Vartela V, Kolovou G.<\/p>\n Lupus. 2018 Apr;27(4):564-571. doi: 10.1177\/0961203317731533. Epub 2017 Sep 19.<\/p>\n PMID: 28927316<\/p>\n Brief Report: Drug-Free Long-Term Remission in Severe Beh\u00e7et’s Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment.<\/a><\/p>\n Sfikakis PP, Arida A, Panopoulos S, Fragiadaki K, Pentazos G, Laskari K, Tektonidou M, Markomichelakis N.<\/p>\n Arthritis Rheumatol. 2017 Dec;69(12):2380-2385. doi: 10.1002\/art.40235. Epub 2017 Nov 8.<\/p>\n PMID: 28834393<\/p>\n Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016.<\/a><\/p>\n Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM.<\/p>\n Ann Rheum Dis. 2017 Dec;76(12):2009-2016. doi: 10.1136\/annrheumdis-2017-211663. Epub 2017 Aug 9. Review. Erratum in: Ann Rheum Dis. 2018 Mar;77(3):472<\/a>.<\/p>\n PMID: 28794077<\/p>\n Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.<\/a><\/p>\n Erkan D, Unlu O, Sciascia S, Belmont HM, Branch DW, Cuadrado MJ, Gonzalez E, Knight JS, Uthman I, Willis R, Zhang Z, Wahl D, Zuily S, Tektonidou MG; APS ACTION.<\/p>\n Lupus. 2018 Mar;27(3):399-406. doi: 10.1177\/0961203317724219. Epub 2017 Aug 1.<\/p>\n PMID: 28764618<\/p>\n Obesity and cardiovascular disease: revisiting an old relationship.<\/a><\/p>\n Koliaki C, Liatis S, Kokkinos A.<\/p>\n Metabolism. 2018 Nov 3. pii: S0026-0495(18)30229-4. doi: 10.1016\/j.metabol.2018.10.011. [Epub ahead of print] Review.<\/p>\n PMID: 30399375<\/p>\n Plasma Irisin Levels in Subjects with Type 1 Diabetes: Comparison with Healthy Controls.<\/a><\/p>\n Comment on: Adiponectin gene variant RS rs266729: Relation to lipid profile changes and circulating adiponectin after bariatric surgery.<\/a><\/p>\n Koliaki C, Kokkinos A.<\/p>\n Surg Obes Relat Dis. 2018 Sep;14(9):1408-1410. doi: 10.1016\/j.soard.2018.06.025. Epub 2018 Jul 1. No abstract available.<\/p>\n PMID: 30061069<\/p>\n Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease.<\/a><\/p>\n Asprouli E, Kalafati I, Sakellari A, Karavoltsos S, Vlachogiannakos J, Revenas K, Kokkinos A, Dassenakis M, Dedoussis GV, Kalogeropoulos N.<\/p>\n Biol Trace Elem Res. 2018 Jul 16. doi: 10.1007\/s12011-018-1432-9. [Epub ahead of print]<\/p>\n PMID: 30014284<\/p>\n Dietary patterns in NAFLD and their interaction with polymorphisms in PNPLA3 and TM6SF2 genes.<\/a><\/p>\n Borsa D, Kalafati IP, Vlachogiannakos J, Revenas K, Kokkinos A, Ladas S, Dedoussis G.<\/p>\n Clin Nutr ESPEN. 2018 Apr;24:182. doi: 10.1016\/j.clnesp.2018.01.041. Epub 2018 Mar 22. No abstract available.<\/p>\n PMID: 29616948<\/p>\n Adherence to the Mediterranean diet and metabolic parameters in patients with chronic kidney disease stage 5.<\/a><\/p>\n Papageorgiou O, Poulia KA, Skalioti CN, Melexopoulou C, Kokkinos A, Perrea D, Boletis IN.<\/p>\n Clin Nutr ESPEN. 2018 Apr;24:176. doi: 10.1016\/j.clnesp.2018.01.020. Epub 2018 Mar 22. No abstract available.<\/p>\n PMID: 29616930<\/p>\n Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case-control study.<\/a><\/p>\n Kalafati IP, Dimitriou M, Borsa D, Vlachogiannakos J, Revenas K, Kokkinos A, Ladas SD, Dedoussis GV.<\/p>\n Eur J Nutr. 2018 Mar 24. doi: 10.1007\/s00394-018-1675-4. [Epub ahead of print]<\/p>\n PMID: 29574608<\/p>\n The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.<\/a><\/p>\n Tentolouris A, Eleftheriadou I, Grigoropoulou P, Kokkinos A, Siasos G, Ntanasis-Stathopoulos I, Tentolouris N.<\/p>\n J Diabetes Complications. 2017 Nov;31(11):1624-1629. doi: 10.1016\/j.jdiacomp.2017.07.010. Epub 2017 Jul 27.<\/p>\n PMID: 28893495<\/p>\n The role of bariatric surgery to treat diabetes: current challenges and perspectives.<\/a><\/p>\n Koliaki C, Liatis S, le Roux CW, Kokkinos A.<\/p>\n BMC Endocr Disord. 2017 Aug 10;17(1):50. doi: 10.1186\/s12902-017-0202-6. Review.<\/p>\n PMID: 28797248<\/p>\n A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326.<\/a><\/p>\n Kaliora AC, Kalafati IP, Gioxari A, Diolintzi A, Kokkinos A, Dedoussis GV.<\/p>\n Eur J Nutr. 2018 Sep;57(6):2227-2235. doi: 10.1007\/s00394-017-1499-7. Epub 2017 Jul 10.<\/p>\n PMID: 28695325<\/p>\n Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications.<\/a><\/p>\n Eleftheriadou I, Grigoropoulou P, Liberopoulos E, Liatis S, Kokkinos A, Tentolouris N.<\/p>\n Curr Med Chem. 2018;25(13):1549-1566. doi: 10.2174\/0929867324666170530075533.<\/p>\n PMID: 28554326<\/p>\n Prostatic abscess in a patient with chronic granulomatous disease: a multi-disciplinary intervention.<\/a><\/p>\n Martini A, Katafigiotis I, Kalantzi S, Anastasiou I, Adamakis I, Toskas A, Constantinides CA.<\/p>\n Urologia. 2017 Feb 8:0. doi: 10.5301\/uro.5000216. [Epub ahead of print]<\/p>\n PMID: 28218357<\/p>\n Clinical pharmacology of glucagon-like peptide-1 receptor agonists.<\/a><\/p>\n Sfairopoulos D, Liatis S, Tigas S, Liberopoulos E.<\/p>\n Hormones (Athens). 2018 Sep;17(3):333-350. doi: 10.1007\/s42000-018-0038-0. Epub 2018 Jun 12. Review.<\/p>\n PMID: 29949126<\/p>\n Thermal heterogeneity of carotid arteries as a novel biomarker in patients with diabetes mellitus assessed for coronary artery disease.<\/a><\/p>\n Tzanis G, Bonou M, Benetos G, Biliou S, Liatis S, Kapelios C, Toutouzas K, Tousoulis D, Barbetseas J.<\/p>\n Int J Cardiol. 2018 Jul 1;262:20-24. doi: 10.1016\/j.ijcard.2018.03.102. Epub 2018 Mar 29.<\/p>\n PMID: 29605471<\/p>\n Liraglutide and Renal Outcomes in Type 2 Diabetes.<\/a><\/p>\n Mann JFE, \u00d8rsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Torn\u00f8e K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.<\/p>\n N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056\/NEJMoa1616011.<\/p>\n PMID: 28854085<\/p>\n Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.<\/a><\/p>\n Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group.<\/p>\n N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056\/NEJMoa1615692. Epub 2017 Jun 12.<\/p>\n PMID: 28605603<\/p>\n Outpatient parenteral antimicrobial therapy (OPAT) in the UK: a cross-sectional survey of acute hospital trusts and health boards.<\/a><\/p>\n Durojaiye OC, Cartwright K, Ntziora F.<\/p>\n Diagn Microbiol Infect Dis. 2018 Jul 24. pii: S0732-8893(18)30249-9. doi: 10.1016\/j.diagmicrobio.2018.07.013. [Epub ahead of print]<\/p>\n PMID: 30098851<\/p>\n